2101 - 2110 of 7730 Results
Title
Year
-
RESTRICTEDTitle: Movement disorders research in 2021: cracking the paradigmJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 1Start Page: 10End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00413-0Citation Count: 15
- NigraNet: An automatic framework to assess nigral neuromelanin content in early Parkinson’s disease using convolutional neural network2022RESTRICTEDTitle: NigraNet: An automatic framework to assess nigral neuromelanin content in early Parkinson’s disease using convolutional neural networkJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 36Issue #:Start Page: 103250End Page: 103250Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2022.103250Best OA location URL: https://doi.org/10.1016/j.nicl.2022.103250Citation Count: 5
- Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL‐AD preclinical testing core study2022RESTRICTEDTitle: Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL‐AD preclinical testing core studyJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12329Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398229Citation Count: 12
-
RESTRICTEDTitle: Poster SessionJournal Name: Rinsho ShinkeigakuPublisher: Societas Neurologica JaponicaVol: 62Issue #: SupplementStart Page: S247End Page: S393Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.5692/clinicalneurol.62_supplement_s247Best OA location URL: https://www.jstage.jst.go.jp/article/clinicalneurol/62/Supplement/62_62_supplement_S247/_pdfCitation Count: 0
- POSTERS - 15th Conference Clinical Trials Alzheimer’s Disease, November 29- December 2, 2022, San Francisco, CA, USA2022RESTRICTEDTitle: POSTERS - 15th Conference Clinical Trials Alzheimer’s Disease, November 29- December 2, 2022, San Francisco, CA, USAJournal Name: The Journal of Prevention of Alzheimer's DiseasePublisher: SERDIVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.14283/jpad.2022.97Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734609Citation Count: 2
- Profiles of women in science: Malú Gámez Tansey, Norman and Susan Fixel Professor of Neuroscience and Neurology, Co‐Director of the Center for Translational Research in Neurodegenerative Disease and Director of the Parkinson's Foundation Research Center of Excellence, University of Florida College of Medicine2022RESTRICTEDTitle: Profiles of women in science: Malú Gámez Tansey, Norman and Susan Fixel Professor of Neuroscience and Neurology, Co‐Director of the Center for Translational Research in Neurodegenerative Disease and Director of the Parkinson's Foundation Research Center of Excellence, University of Florida College of MedicineJournal Name: European Journal of NeurosciencePublisher: WileyVol: 55Issue #: 2Start Page: 350End Page: 353Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.15578Citation Count: 0
-
RESTRICTEDTitle: Profiling Parkinson’s disease cognitive phenotypes via resting-state magnetoencephalographyJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 127Issue #: 1Start Page: 279End Page: 289Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1152/jn.00316.2021Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782645Citation Count: 8
- Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study2022RESTRICTEDTitle: Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 1Start Page: 53End Page: 65Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00368-9Citation Count: 39
-
RESTRICTEDTitle: Should “on-demand” treatments for Parkinson’s disease OFF episodes be used earlier?Journal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 7Issue #:Start Page: 100161End Page: 100161Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100161Best OA location URL: https://doi.org/10.1016/j.prdoa.2022.100161Citation Count: 7
-
RESTRICTEDTitle: Sorting (Nexin-13) out Novel Insights into Endolysosomal Cholesterol ExportJournal Name: ContactPublisher: SAGE PublicationsVol: 5Issue #:Start Page: 251525642211145End Page: 251525642211145Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/25152564221114513Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/25152564221114513Citation Count: 1